BioNTech SE Adjustments For Share-based Payments
BioNTech SE (BNTX) reported Adjustments For Share-based Payments of EUR 106.20 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:AdjustmentsForSharebasedPayments · last filed 2026-03-10
| Period end | Adjustments For Share-based Payments 12 month | Adjustments For Share-based Payments 12 month as first filed |
|---|---|---|
| 2025-12-31 | 106.20M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 100.90M EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 51.40M EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 108.60M EUR 20-F · filed 2025-03-10 | |
| 2021-12-31 | 93.90M EUR 20-F · filed 2024-03-20 | 80.50M EUR 20-F · filed 2022-03-30 |
| 2020-12-31 | 32.10M EUR 20-F · filed 2023-03-27 | 32.14M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 30.20M EUR 20-F/A · filed 2022-10-26 | 30.23M EUR 20-F · filed 2020-03-31 |
| 2018-12-31 | 7.64M EUR 20-F · filed 2021-03-30 | |
| 2017-12-31 | 5.91M EUR 20-F · filed 2020-03-31 |